Abstract: The present review provides a description of recent advances in the field of functional imaging that takes advantage of the functional characteristics of thyroid neoplastic cells (such as radioiodine uptake and FDG uptake) and theragnostic approach of differentiated thyroid cancer (DTC). Physical and biological characteristics of available radiopharmaceuticals and their use with state-of-the-art technologies for diagnosis, treatment, and follow-up of DTC patients are depicted. Radioactive iodine is used mostly with a therapeutic intent, while PET/CT with 18F-FDG emerges as a useful tool in the diagnostic management and complements the use of radioactive iodine. Beyond 18F-FDG PET/CT, other tracers including 124I, 18F-TFB and 68Ga-PSMA, and new methods such as PET/MR, might offer new opportunities in selecting patients with DTC for specific imaging modalities or treatments.

Advances in functional imaging of differentiated thyroid cancer / Klain, Michele; Zampella, Emilia; Nappi, Carmela; Nicolai, Emanuele; Ambrosio, Raffaele; Califaretti, Elena; Lamartina, Livia; Schlumberger, Martin; Deandreis, Désirée; Salvatore, Domenico; Cuocolo, Alberto. - In: CANCERS. - ISSN 2072-6694. - 13:19(2021), pp. 4748-4768. [10.3390/cancers13194748]

Advances in functional imaging of differentiated thyroid cancer

Klain, Michele;Zampella, Emilia;Nappi, Carmela;Ambrosio, Raffaele;Salvatore, Domenico;Cuocolo, Alberto
2021

Abstract

Abstract: The present review provides a description of recent advances in the field of functional imaging that takes advantage of the functional characteristics of thyroid neoplastic cells (such as radioiodine uptake and FDG uptake) and theragnostic approach of differentiated thyroid cancer (DTC). Physical and biological characteristics of available radiopharmaceuticals and their use with state-of-the-art technologies for diagnosis, treatment, and follow-up of DTC patients are depicted. Radioactive iodine is used mostly with a therapeutic intent, while PET/CT with 18F-FDG emerges as a useful tool in the diagnostic management and complements the use of radioactive iodine. Beyond 18F-FDG PET/CT, other tracers including 124I, 18F-TFB and 68Ga-PSMA, and new methods such as PET/MR, might offer new opportunities in selecting patients with DTC for specific imaging modalities or treatments.
2021
Advances in functional imaging of differentiated thyroid cancer / Klain, Michele; Zampella, Emilia; Nappi, Carmela; Nicolai, Emanuele; Ambrosio, Raffaele; Califaretti, Elena; Lamartina, Livia; Schlumberger, Martin; Deandreis, Désirée; Salvatore, Domenico; Cuocolo, Alberto. - In: CANCERS. - ISSN 2072-6694. - 13:19(2021), pp. 4748-4768. [10.3390/cancers13194748]
File in questo prodotto:
File Dimensione Formato  
Klain et al. Cancers (2021).pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Licenza: Dominio pubblico
Dimensione 3.6 MB
Formato Adobe PDF
3.6 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/858374
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 10
social impact